Jintropin belongs to the pharma group of polypeptide hormones, synthesized in the laboratory and essentially a genetically modified somatotropic human growth hormone. 

Release form.

Lyophilisate for the preparation of a solution for subcutaneous administration 10 vials

Solvent: water for injection in an ampoule in the amount of 10 pieces.

Composition

1 vial contains somatropic hormone 3.33 mg, which corresponds to (10 IU)

In addition to somatropic hormone, the vial contains excipients:

 mannitol

glycine

sodium dihydrogen phosphate

 sodium chloride.